Clinical Trials Browser

OTHER × Breakthrough Pain × Infusions, Intravenous × Clear all

NCT05053308 2023-08-07

Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement

Phase NA Withdrawn

Cancer Pain, Breakthrough Pain